| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.227 | 64.224 | 65.807 | 122.289 | 115.186 | 89.160 | 172.675 | 166.567 | 179.375 |
| Total Income - EUR | - | 2.227 | 64.224 | 65.807 | 123.975 | 131.518 | 117.984 | 189.911 | 222.373 | 288.112 |
| Total Expenses - EUR | - | 1.394 | 55.949 | 64.458 | 112.058 | 128.400 | 114.724 | 184.731 | 218.542 | 266.851 |
| Gross Profit/Loss - EUR | - | 832 | 8.275 | 1.349 | 11.917 | 3.118 | 3.260 | 5.180 | 3.831 | 21.261 |
| Net Profit/Loss - EUR | - | 766 | 7.633 | 691 | 10.677 | 1.803 | 2.081 | 3.281 | 1.607 | 12.618 |
| Employees | - | 0 | 4 | 5 | 3 | 8 | 4 | 3 | 4 | 4 |
Check the financial reports for the company - Rusmedan S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 10.249 | 14.071 | 13.233 | 43.609 | 37.073 | 78.401 | 79.584 | 95.048 | 80.711 |
| Current Assets | - | 252 | 24.825 | 19.041 | 16.086 | 58.343 | 79.175 | 68.400 | 44.438 | 83.476 |
| Inventories | - | 0 | 10.435 | 18.823 | 12.686 | 46.005 | 71.249 | 57.566 | 36.598 | 67.910 |
| Receivables | - | 0 | 3.654 | 50 | 501 | 0 | 7.869 | 9.303 | 7.230 | 15.349 |
| Cash | - | 252 | 10.736 | 167 | 2.900 | 12.337 | 57 | 1.531 | 611 | 217 |
| Shareholders Funds | - | 810 | 8.430 | 8.966 | 19.469 | 20.903 | 22.520 | 25.871 | 27.399 | 39.864 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 9.691 | 30.466 | 23.307 | 40.225 | 74.513 | 135.056 | 122.113 | 112.088 | 124.323 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5610 - 5610" | |||||||||
| CAEN Financial Year |
5610
|
|||||||||
Comments - Rusmedan S.r.l.